BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. Br J Surg. 1997;84:1470-1473. [PMID: 9361616 DOI: 10.1002/bjs.1800841035] [Cited by in Crossref: 119] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Wolfsen HC. Endoluminal Therapy for Barrett's Esophagus. Gastrointestinal Endoscopy Clinics of North America 2007;17:59-82. [DOI: 10.1016/j.giec.2006.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
2 Patel M, Ferry K, Franceschi D, Kaklamanos I, Livingstone A, Ardalan B. Esophageal Carcinoma: Current Controversial Topics. Cancer Investigation 2004;22:897-912. [DOI: 10.1081/cnv-200039672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Dolan K, Morris AI, Gosney JR, Field JK, Sutton R. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease? J Gastroenterol Hepatol 2004;19:24-30. [PMID: 14675239 DOI: 10.1111/j.1440-1746.2004.03280.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
4 Stolte M, Dostler I. Good handling and pathological examination of endoscopic resections of early Barrett's cancer. Diagnostic Histopathology 2012;18:498-502. [DOI: 10.1016/j.mpdhp.2012.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Bollschweiler E, Metzger R, Drebber U, Baldus S, Vallböhmer D, Kocher M, Hölscher AH. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol. 2009;20:231-238. [PMID: 18836090 DOI: 10.1093/annonc/mdn622] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
6 Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652-660.e1. [PMID: 24269290 DOI: 10.1053/j.gastro.2013.11.006] [Cited by in Crossref: 267] [Cited by in F6Publishing: 210] [Article Influence: 29.7] [Reference Citation Analysis]
7 Vrouenraets BC, van Lanschot JJB. Extent of Surgical Resection for Esophageal and Gastroesophageal Junction Adenocarcinomas. Surgical Oncology Clinics of North America 2006;15:781-91. [DOI: 10.1016/j.soc.2006.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
8 Wong RF, Bhutani MS. Therapeutic endoscopy and endoscopic ultrasound for gastrointestinal malignancies. Expert Review of Anticancer Therapy 2014;5:705-18. [DOI: 10.1586/14737140.5.4.705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
9 Dunn JR, Risk JM, Langan JE, Marlee D, Ellis A, Campbell F, Watson AJM, Field JK. Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma. Oncogene 2003;22:4134-42. [DOI: 10.1038/sj.onc.1206466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
10 Schiesser M, Schneider PM. Surgical strategies for adenocarcinoma of the esophagogastric junction. Recent Results Cancer Res. 2010;182:93-106. [PMID: 20676874 DOI: 10.1007/978-3-540-70579-6_8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
11 Bennett C, Green S, Barr H, Bhandari P, Decaestecker J, Ragunath K, Singh R, Tawil A, Jankowski J. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev 2010;:CD007334. [PMID: 20464752 DOI: 10.1002/14651858.CD007334.pub3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384. [PMID: 21651355 DOI: 10.1586/egh.11.33] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
13 Brock MV, Are C, Wu T, Canto M, Yang SC, Heitmiller RF. Polypoid esophageal adenocarcinoma—a clinicopathological variant of esophageal cancer? Current Surgery 2002;59:336-41. [DOI: 10.1016/s0149-7944(01)00598-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Reed CE. Surgical Management of Esophageal Carcinoma. The Oncologist 1999;4:95-105. [DOI: 10.1634/theoncologist.4-2-95] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
15 Yagi K, Nakamura A, Sekine A, Tamiya Y, Oyamatsu M. Magnified view of adenocarcinoma in short segment Barrett's esophagus treated by endoscopic mucosal resection. Gastrointestinal Endoscopy 2002;55:278-81. [DOI: 10.1067/mge.2002.120882] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
16 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001;54:689-696. [PMID: 11726843 DOI: 10.1067/mge.2001.119216] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 5.0] [Reference Citation Analysis]
18 Feith M, Stein HJ, Mueller J, Siewert JR. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53. Dis Esophagus 2004;17:322-7. [PMID: 15569371 DOI: 10.1111/j.1442-2050.2004.00434.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
19 Yamamoto H. Technology insight: endoscopic submucosal dissection of gastrointestinal neoplasms. Nat Clin Pract Gastroenterol Hepatol. 2007;4:511-520. [PMID: 17768396 DOI: 10.1038/ncpgasthep0906] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
20 Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J. Optimizing Treatment of Carcinoma of the Esophagus and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2001;10:863-84. [DOI: 10.1016/s1055-3207(18)30037-1] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
21 Todd JA, de Caestecker J. Surgery or endotherapy for high-grade dysplasia/early adenocarcinoma in Barrett's oesophagus? Eur J Gastroenterol Hepatol 2002;14:1049-51. [PMID: 12362092 DOI: 10.1097/00042737-200210000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Schröder W, Wirths K, Gutschow C, Vallböhmer D, Bludau M, Schumacher B, Neuhaus H, Hölscher AH. Transthoracic Esophagectomy After Endoscopic Mucosal Resection in Patients with Early Esophageal Carcinoma. J Gastrointest Surg 2009;13:223-9. [DOI: 10.1007/s11605-008-0719-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Belghazi K, Bergman JJGHM, Pouw RE. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Gastrointest Endosc Clin N Am 2017;27:461-70. [PMID: 28577767 DOI: 10.1016/j.giec.2017.02.004] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Bellizzi AM, Odze RD. Histopathology of Barrett's esophagus: A review for the practicing gastroenterologist. Techniques in Gastrointestinal Endoscopy 2010;12:69-81. [DOI: 10.1016/j.tgie.2010.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg. 2000;232:733-742. [PMID: 11088068 DOI: 10.1097/00000658-200012000-00002] [Cited by in Crossref: 244] [Cited by in F6Publishing: 197] [Article Influence: 11.1] [Reference Citation Analysis]
26 Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG. Long-term outcomes of patients with Barrett’s esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointest Endosc. 2013;77:190-199. [PMID: 23317687 DOI: 10.1016/j.gie.2012.10.013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
27 Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc. 2007;65:3-10. [PMID: 17185072 DOI: 10.1016/j.gie.2006.04.033] [Cited by in Crossref: 367] [Cited by in F6Publishing: 299] [Article Influence: 24.5] [Reference Citation Analysis]
28 Gossner L. The role of endoscopic resection and ablation therapy for early lesions. Best Practice & Research Clinical Gastroenterology 2006;20:867-76. [DOI: 10.1016/j.bpg.2006.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
29 Harada M, Nagashima R, Takeda H, Takahashi T. Endoscopic resection of adenocarcinoma arising in a tongue of Barrett's esophagus. Gastrointestinal Endoscopy 2000;52:427-9. [DOI: 10.1067/mge.2000.108298] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Bennett C, Green S, Decaestecker J, Almond M, Barr H, Bhandari P, Ragunath K, Singh R, Jankowski J. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev 2012;11:CD007334. [PMID: 23152243 DOI: 10.1002/14651858.CD007334.pub4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Sampliner RE. Appearance and prognosis of dysplasia in Barrett's esophagus. Chest Surgery Clinics of North America 2002;12:69-76. [DOI: 10.1016/s1052-3359(03)00066-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Mariette C, Piessen G, Balon J, Van Seuningen I, Triboulet J. Surgery alone in the curative treatment of localised oesophageal carcinoma. European Journal of Surgical Oncology (EJSO) 2004;30:869-76. [DOI: 10.1016/j.ejso.2004.06.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
33 Qumseya BJ, Panossian AM, Rizk C, Cangemi DJ, Wolfsen C, Raimondo M, Woodward TA, Wallace MB, Wolfsen HC. Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection. Dig Liver Dis 2013;45:1028-33. [PMID: 23938135 DOI: 10.1016/j.dld.2013.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
34 Pech O, Gossner L, May A, Ell C. Management of Barrett's oesophagus, dysplasia and early adenocarcinoma. Best Pract Res Clin Gastroenterol. 2001;15:267-284. [PMID: 11355915 DOI: 10.1053/bega.2001.0173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
35 Lundell L. Surgical therapies in Barrett's esophagus. Gastrointest Endosc Clin N Am 2003;13:433-47, vi. [PMID: 14629100 DOI: 10.1016/s1052-5157(03)00046-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
36 Hironaka S, Boku N, Ohtsu A, Ochiai A, Yoshida S, Ejiri Y. Endoscopic mucosal resection for early adenocarcinoma arising in Barrett's esophagus. Digestive Endoscopy 2002;13:104-7. [DOI: 10.1046/j.1443-1661.2001.00100.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Peters FP, Kara MA, Rosmolen WD, Aalders MC, Ten Kate FJ, Bultje BC, Krishnadath KK, Fockens P, van Lanschot JJ, van Deventer SJ. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;61:506-514. [PMID: 15812401 DOI: 10.1016/s0016-5107(05)00063-5] [Cited by in Crossref: 124] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
38 Stein H, von Rahden B, Feith M. Surgery for early stage esophageal adenocarcinoma. J Surg Oncol 2005;92:210-7. [DOI: 10.1002/jso.20362] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
39 Manner H, May A, Pech O, Gossner L, Rabenstein T, Günter E, Vieth M, Stolte M, Ell C. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008;103:2589-2597. [PMID: 18785950 DOI: 10.1111/j.1572-0241.2008.02083.x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 136] [Article Influence: 11.4] [Reference Citation Analysis]
40 Pech O, Gossner L, May A, Rabenstein T, Vieth M, Stolte M, Berres M, Ell C. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc. 2005;62:24-30. [PMID: 15990815 DOI: 10.1016/s0016-5107(05)00333-0] [Cited by in Crossref: 147] [Cited by in F6Publishing: 31] [Article Influence: 8.6] [Reference Citation Analysis]
41 Vienne A, Prat F. [Endoscopic treatments for Barrett oesophagus]. Presse Med 2011;40:516-28. [PMID: 21474270 DOI: 10.1016/j.lpm.2011.02.022] [Reference Citation Analysis]
42 Panjehpour M, Overholt BF. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers Surg Med 2006;38:390-5. [DOI: 10.1002/lsm.20367] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
43 Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association Technical Review on the Role of the Gastroenterologist in the Management of Esophageal Carcinoma. Gastroenterology 2005;128:1471-505. [DOI: 10.1053/j.gastro.2005.03.077] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
44 Gamboa AM, Kim S, Force SD, Staley CA, Woods KE, Kooby DA, Maithel SK, Luke JA, Shaffer KM, Dacha S, Saba NF, Keilin SA, Cai Q, El-Rayes BF, Chen Z, Willingham FF. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement. Cancer. 2016;122:2150-2157. [PMID: 27142247 DOI: 10.1002/cncr.30040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
45 Theisen J, Feith M, Stein HJ, Siewert JR. Management of early esophageal cancer. Adv Surg 2007;41:229-39. [PMID: 17972568 DOI: 10.1016/j.yasu.2007.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Green S, Tawil A, Barr H, Bennett C, Bhandari P, Decaestecker J, Ragunath K, Singh R, Jankowski J. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev 2009;:CD007334. [PMID: 19370683 DOI: 10.1002/14651858.CD007334.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002;9:807-11. [PMID: 12374665 DOI: 10.1007/BF02574504] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
48 Conio M, Repici A, Cestari R, Blanchi S, Lapertosa G, Missale G, Casa DD, Villanacci V, Calandri PG, Filiberti R. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett’s esophagus: An Italian experience. World J Gastroenterol 2005; 11(42): 6650-6655 [PMID: 16425359 DOI: 10.3748/wjg.v11.i42.6650] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
49 Lorenzo-Zúñiga V, Boix J. Endoscopic mucosal resection and mucosa ablation with argon-plasma coagulation in a high-risk patient with Barrett's oesophagus and oesophageal adenocarcinoma. Dig Liver Dis 2006;38:713-4. [PMID: 16787771 DOI: 10.1016/j.dld.2006.05.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 May A, Gossner L, Pech O, Fritz A, Günter E, Mayer G, Müller H, Seitz G, Vieth M, Stolte M. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol. 2002;14:1085-1091. [PMID: 12362099 DOI: 10.1097/00042737-200210000-00009] [Cited by in Crossref: 269] [Cited by in F6Publishing: 233] [Article Influence: 14.2] [Reference Citation Analysis]
51 Pech O, Nagy CD, Gossner L, May A, Ell C. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice. Eur J Gastroenterol Hepatol. 2002;14:657-662. [PMID: 12072600 DOI: 10.1097/00042737-200206000-00011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
52 Knabe M, May A, Ell C. Endoscopic therapy in early adenocarcinomas (Barrett's cancer) of the esophagus. J Dig Dis 2015;16:363-9. [PMID: 26031930 DOI: 10.1111/1751-2980.12264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Pech O, May A, Gossner L, Ell C. Barrett's esophagus: endoscopic resection. Gastrointest Endosc Clin N Am. 2003;13:505-512. [PMID: 14629106 DOI: 10.1016/s1052-5157(03)00047-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
54 Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A, Gossner L, Stolte M, Vieth M, Ell C. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013;11:630-5; quiz e45. [PMID: 23357492 DOI: 10.1016/j.cgh.2012.12.040] [Cited by in Crossref: 139] [Cited by in F6Publishing: 111] [Article Influence: 15.4] [Reference Citation Analysis]
55 van Sandick JW, van Lanschot JJB, ten Kate FJW, Offerhaus GJA, Fockens P, Tytgat GNJ, Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: Implications for therapeutic decision making. Cancer 2000;88:2429-37. [DOI: 10.1002/1097-0142(20000601)88:11<2429::aid-cncr1>3.0.co;2-h] [Cited by in Crossref: 103] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
56 von Rahden BHA, Stein HJ. Barrett's esophagus with high-grade intraepithelial neoplasia: observation, ablation or resection? Eur Surg 2007;39:249-54. [DOI: 10.1007/s10353-007-0337-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Lovat LB, Jamieson NF, Novelli MR, Mosse CA, Selvasekar C, Mackenzie GD, Thorpe SM, Bown SG. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc. 2005;62:617-623. [PMID: 16185985 DOI: 10.1016/j.gie.2005.04.043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
58 Schröder W, Gutschow CA, Hölscher AH. Limited resection for early esophageal cancer? Langenbecks Arch Surg 2003;388:88-94. [DOI: 10.1007/s00423-003-0371-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
59 Bisschops R. Optimal endoluminal treatment of Barrett’s esophagus: integrating novel strategies into clinical practice. Expert Review of Gastroenterology & Hepatology 2014;4:319-33. [DOI: 10.1586/egh.10.20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
60 Bergman JJGHM. New developments in the endoscopic detection and treatment of early neoplasia in Barrett's oesophagus. Scandinavian Journal of Gastroenterology 2009;41:18-24. [DOI: 10.1080/00365520600664227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Hölscher AH, Schröder W, Mönig SP. Adenocarcinoma in Barrett’s Esophagus — Classification and Staging. In: Tilanus HW, Attwood SEA, editors. Barrett’s Esophagus. Dordrecht: Springer Netherlands; 2001. pp. 297-306. [DOI: 10.1007/978-94-017-0829-6_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
62 Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26-33. [PMID: 11781277 DOI: 10.1053/gast.2002.30297] [Cited by in Crossref: 234] [Cited by in F6Publishing: 197] [Article Influence: 11.7] [Reference Citation Analysis]
63 Murphy TJ, Ravi N, Reynolds JV. Treatment options for esophageal cancer. Expert Opin Pharmacother 2008;9:3197-210. [PMID: 19040340 DOI: 10.1517/14656560802560237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
64 Willingham FF, Brugge WR. Endoscopic mucosal resection for Barrett’s esophagus-related neoplasia. Expert Review of Gastroenterology & Hepatology 2014;1:11-4. [DOI: 10.1586/17474124.1.1.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol. 2009;100:191-198. [PMID: 19548259 DOI: 10.1002/jso.21336] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
66 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
67 Stein H, Feith M. Surgical strategies for early esophageal adenocarcinoma. Best Practice & Research Clinical Gastroenterology 2005;19:927-40. [DOI: 10.1016/j.bpg.2005.06.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
68 Wang VS, Hornick JL, Sepulveda JA, Mauer R, Poneros JM. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc. 2009;69:777-783. [PMID: 19136106 DOI: 10.1016/j.gie.2008.05.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
69 Stolte M, Kirtil T, Oellig F, Vogel C, Mueller H, May A, Ell C, Wittenberg R. The pattern of invasion of early carcinomas in Barrett's esophagus is dependent on the depth of infiltration. Pathol Res Pract. 2010;206:300-304. [PMID: 20188488 DOI: 10.1016/j.prp.2010.01.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
70 Reed DN Jr, Vitale GC. Interventional endoscopic retrograde cholangiopancreatography and endoscopic surgery. Surg Clin North Am 2000;80:1171-201. [PMID: 10987030 DOI: 10.1016/s0039-6109(05)70219-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
71 Ruol A, Parenti A, Zaninotto G, Merigliano S, Costantini M, Cagol M, Alfieri R, Bonavina L, Peracchia A, Ancona E. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000;88:2520-8. [DOI: 10.1002/1097-0142(20000601)88:11<2520::aid-cncr13>3.0.co;2-l] [Cited by in Crossref: 103] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
72 Satodate H, Inoue H, Yoshida T, Usui S, Iwashita M, Fukami N, Shiokawa A, Kudo SE. Circumferential EMR of carcinoma arising in Barrett’s esophagus: case report. Gastrointest Endosc. 2003;58:288-292. [PMID: 12872107 DOI: 10.1067/mge.2003.361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
73 Bergman JJ. Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett oesophagus. Best Pract Res Clin Gastroenterol. 2005;19:889-907. [PMID: 16338648 DOI: 10.1016/j.bpg.2005.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
74 Tokar JL, Haluszka O, Weinberg DS. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. Semin Radiat Oncol. 2007;17:10-21. [PMID: 17185193 DOI: 10.1016/j.semradonc.2006.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
75 Van Vilsteren FG, Bergman JJ. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus. Gastrointest Endosc Clin N Am. 2010;20:55-74, vi. [PMID: 19951794 DOI: 10.1016/j.giec.2009.07.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
76 Van Lanschot JJB, Ceha HM, Bakker PJ. Surgery, radiotherapy, and chemotherapy for esophageal cancer: . Current Opinion in Gastroenterology 1999;15:370. [DOI: 10.1097/00001574-199907000-00017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
77 Chennat J, Konda VJ, Waxman I. Endotherapy for Barrett's esophagus: Which, how, when, and who? Gastrointest Endosc Clin N Am 2011;21:119-33. [PMID: 21112502 DOI: 10.1016/j.giec.2010.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]